Step 1 topics → Gastrointestinal → Wilson Disease

Wilson Disease

USMLE Step 1 trap: Treats Kayser-Fleischer rings as pathognomonic for Wilson disease rather than highly suggestive. KF rings are highly associated with Wilson disease but can also appear in other cholestatic liver diseases; they are not strictly pathognomonic.

Wilson disease is an autosomal recessive disorder caused by mutations in ATP7B, a copper-transporting ATPase in hepatocytes. The defect has two consequences: copper can't be incorporated into ceruloplasmin (so serum ceruloplasmin is low) and copper can't be excreted into bile (so it accumulates in liver, basal ganglia, and cornea). USMLE Step 1 loves this disease because it hits three organ systems at once and the workup has multiple moving parts that students often oversimplify. The classic presentation is a young patient with liver disease plus neuropsychiatric symptoms plus Kayser-Fleischer rings — but the exam will push you to reason about each piece rather than just pattern-match the triad.

The trickiest part is the diagnostic workup. Students see 'low ceruloplasmin' and immediately write 'Wilson disease confirmed' — that's wrong, and Step 1 will exploit it. Similarly, KF rings are striking and memorable, but they're not pathognomonic; they show up in other cholestatic diseases too. The exam rewards students who understand that diagnosis requires a constellation: low ceruloplasmin, elevated 24-hour urine copper, slit-lamp findings, and often liver biopsy with quantitative copper measurement. Treatment adds another layer — chelation with penicillamine or trientine, with zinc used for maintenance or in asymptomatic patients.

On USMLE Step 1, this topic is tested at the application level. You'll get a vignette with a young adult presenting with elevated transaminases, personality changes, or movement abnormalities, and you'll need to identify the pathophysiology, interpret the labs correctly, and pick the right next diagnostic step or treatment. The genetics angle (autosomal recessive, chromosome 13, ATP7B) also shows up, sometimes in inheritance-pattern questions paired with other AR diseases.

From real student decks
70%have cards covering this topic
51%have mature cards

Common misconceptions

Common mistake
Wrong: Kayser-Fleischer rings are pathognomonic for Wilson disease.
Right: KF rings are highly associated with Wilson disease but can also appear in other cholestatic liver diseases; they are not strictly pathognomonic.
KF rings are a dramatic, high-yield finding, but calling them pathognomonic is an oversimplification that the exam will test against. They appear in other cholestatic liver diseases (like primary biliary cholangitis) where copper also builds up in the cornea due to impaired biliary flow. The clinical context — especially the neuropsychiatric component — is what makes KF rings specifically point to Wilson disease. Always pair KF rings with the rest of the picture before committing to a diagnosis.
Common mistake
Wrong: Low serum ceruloplasmin alone confirms Wilson disease.
Right: Low ceruloplasmin is suggestive but not confirmatory; diagnosis requires 24-hour urine copper, slit-lamp exam, and often liver biopsy with quantitative copper.
Low ceruloplasmin is a helpful screening clue, but it's not a standalone confirmatory test. Ceruloplasmin is an acute-phase reactant, so it can be falsely normal during inflammation, and it can be low in other conditions like protein-losing states or Menkes disease. The gold-standard workup requires 24-hour urine copper (elevated in Wilson disease), slit-lamp exam for KF rings, and liver biopsy with quantitative copper if the diagnosis is still uncertain. Treating low ceruloplasmin as diagnostic will get you the wrong answer.
Common mistake
Wrong: Wilson disease causes copper deficiency due to impaired absorption.
Right: ATP7B mutation impairs biliary copper excretion and incorporation into ceruloplasmin, causing copper accumulation in liver, brain, and cornea.
Wilson disease is entirely a copper accumulation disorder — it has nothing to do with copper deficiency or impaired absorption from the gut. ATP7B is expressed in hepatocytes and functions in two places: packaging copper into ceruloplasmin for secretion, and transporting copper into bile for excretion. When ATP7B fails, copper builds up first in the liver, then spills into the bloodstream and deposits in the brain (basal ganglia especially) and cornea. Confusing this with Menkes disease — which actually does involve impaired copper absorption and leads to copper deficiency — is a classic trap.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know how the ATP7B mutation causes copper accumulation — not absorption failure, but failure of biliary excretion and ceruloplasmin loading — and trace why each organ is affected as a result.
  2. Recognize the full clinical triad of Wilson disease: hepatic dysfunction (ranging from elevated LFTs to cirrhosis or acute liver failure), neuropsychiatric symptoms (personality change, dysarthria, tremor, parkinsonism), and Kayser-Fleischer rings on slit-lamp exam.
  3. Understand the stepwise diagnostic workup and why no single test confirms the diagnosis — low ceruloplasmin is suggestive, but 24-hour urine copper, slit-lamp exam, and liver biopsy with quantitative copper are needed for confirmation.

Can you avoid these mistakes?

A 19-year-old presents with a 6-month history of mood changes and mild jaundice. Labs show elevated AST/ALT, low ceruloplasmin, and a 24-hour urine copper of 180 µg/day (normal <100). Slit-lamp shows golden-brown corneal rings. What is the mechanism that explains all of his findings?
You see a 35-year-old woman with primary biliary cholangitis who also has Kayser-Fleischer rings on slit-lamp. A medical student says this confirms she also has Wilson disease. How do you correct that reasoning?
A patient is newly diagnosed with Wilson disease but is currently asymptomatic, found incidentally during family screening. Serum ceruloplasmin is low and 24-hour urine copper is borderline elevated. What is the most appropriate initial management — chelation with penicillamine, chelation with trientine, or zinc supplementation — and why?
A 22-year-old presents with acute liver failure, hemolytic anemia, and psychiatric symptoms. His ceruloplasmin comes back normal. Does a normal ceruloplasmin rule out Wilson disease? Explain why or why not.

Related topics

Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →